XML 40 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Restricted Stock Activity
Restricted stock activity for the year ended December 31, 2023 and the three months ended March 31, 2024 was as follows:
RSAWeighted Average Grant PricePRSUWeighted Average Grant PriceRSUWeighted Average Grant PriceTotalWeighted Average Grant Price
Nonvested balance as of December 31, 2022133,317 $27.95 57,435 $32.89 6,105 $25.92 196,857 $29.32 
Granted (1)
— — 34,840 35.79 54,955 34.43 89,795 34.96 
Vested(56,931)27.03 (36,120)31.31 (3,253)26.06 (96,304)28.60 
Forfeited(4,435)30.20 — — (820)36.42 (5,255)31.17 
Nonvested balance as of December 31, 202371,951 28.53 56,155 35.70 56,987 33.97 185,093 32.38 
Granted (1)
— — 17,025 42.89 46,025 36.08 63,050 32.78 
Vested(32,211)26.87 — — (13,264)34.47 (45,475)29.09 
Forfeited(5,085)30.33 — — (3,875)36.30 (8,960)32.91 
Nonvested balance as of March 31, 202434,655 $29.81 73,180 $37.37 85,873 $34.92 193,708 $34.93 
Unrecognized compensation cost (in thousands)$911 $1,559 $2,709 $5,179 
Weighted average remaining recognition period (in years)1.592.153.202.60
(1)The number of restricted shares/units shown includes the shares that would be granted if the target level of performance is achieved related to the PRSU. The number of shares actually issued may vary.
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Share-based compensation expense related to restricted stock and ESPP included in the unaudited Consolidated Statements of Income was as follows:
For the Three Months Ended March 31,
20242023
(In Thousands)
Share-based compensation expense$665 $634